Consensus STAAR Surgical Company Deutsche Boerse AG

Equities

SR3

US8523123052

Market Closed - Deutsche Boerse AG Other stock markets 02:06:31 2024-05-03 EDT			5-day change	1st Jan Change
42.29 ^EUR	+1.95%		-3.78%	+46.38%

05-01	STAAR Surgical Strengthens Leadership Team with Appointments of Nancy Sabin as Chief Marketing Officer and Nathaniel Sisitsky as General Counsel	CI
04-11	Mizuho Adjusts Price Target on STAAR Surgical to $53 From $45, Maintains Buy Rating	MT

Evolution of the average Target Price on STAAR Surgical Company

Price target over the last 5 years

History of analyst recommendation changes

5074799047a4c20048.EWpoNuQNwchlvGVO2GpKVIYv9fFL2HKoUxBb53Bd6fg.Xw8vDotjiYQL8S8K7gUnG_Vhqpo76F_eO18RowUknro8GypUrUqppTToIA~ea6290408cae81f7b0ff51c3784f8619

Analyst Recommendations on STAAR Surgical Company

Mizuho Adjusts Price Target on STAAR Surgical to $53 From $45, Maintains Buy Rating	04-11	MT
Canaccord Genuity Raises Price Target on STAAR Surgical to $46 From $32, Maintains Hold Rating	04-08	MT
Stifel Upgrades STAAR Surgical to Buy From Hold, Raises Price Target to $50 From $30	03-11	MT
Mizuho Securities Adjusts Price Target on STAAR Surgical to $45 From $50, Keeps Buy Rating	02-28	MT
Piper Sandler Cuts STAAR Surgical Price Target to $33 From $40, Maintains Neutral Rating	02-27	MT
Needham Downgrades STAAR Surgical to Hold From Buy	12-05	MT
Morgan Stanley Initiates STAAR Surgical at Equal-Weight Rating With $35 Price Target	12-04	MT
Needham Adjusts Price Target on STAAR Surgical Company to $49 From $52, Keeps Buy Rating	11-02	MT
Stifel Lowers Price Target on STAAR Surgical to $40 From $45, Maintains Hold Rating	23-09-22	MT
Piper Sandler Adjusts Price Target on STAAR Surgical Company to $45 From $50, Keeps Neutral Rating	23-09-15	MT
Canaccord Genuity Adjusts STAAR Surgical Price Target to $43 From $48, Maintains Hold Rating	23-09-15	MT
Needham Cuts STAAR Surgical's Price Target to 52 From $54, Keeps Buy Rating	23-09-15	MT
Benchmark Downgrades STAAR Surgical to Hold From Buy	23-09-15	MT
Stifel Adjusts Price Target on STAAR Surgical Company to $45 From $50, Maintains Hold Rating	23-08-21	MT
Needham Adjusts Price Target on STAAR Surgical to $58 From $75, Maintains Buy Rating	23-08-03	MT
Canaccord Genuity Downgrades STAAR Surgical to Hold From Buy, Adjusts Price Target to $48 From $77	23-08-03	MT
ANALYST RECOMMENDATIONS : Ferrari, Qualcomm, Zillow, Roku, Southwest Airlines...	23-08-03
Stifel Cuts Price Target on STAAR Surgical to $55 From $60, Maintains Hold Rating	23-06-12	MT
William Blair Downgrades STAAR Surgical Company to Market Perform From Outperform	23-06-07	MT
Needham Adjusts Price Target on STAAR Surgical to $84 From $78, Maintains Buy Rating	23-05-04	MT
Piper Sandler Starts STAAR Surgical at Neutral With $65 Price Target	23-04-17	MT
ANALYST RECOMMENDATIONS : Biogen, Diageo, HP, Meta, Wolfspeed...	23-04-17
Needham Cuts Price Target on STAAR Surgical Company to $78 From $83, Keeps Buy Rating	23-02-22	MT
BTIG Downgrades STAAR Surgical to Neutral From Buy	23-02-06	MT
Benchmark Adjusts Price Target on STAAR Surgical Company to $75 From $78, Maintains Buy Rating	23-02-01	MT

More recommendations

Analysts' Consensus

Sell

Buy

Mean consensus

OUTPERFORM

Number of Analysts

Last Close Price

45.51 USD

Average target price

49.17 USD

Spread / Average Target

+8.03%

High Price Target

60 USD

Spread / Highest target

+31.84%

Low Price Target

33 USD

Spread / Lowest Target

-27.49%

Consensus detail

Consensus revision (last 18 months)

Analysts covering STAAR Surgical Company

Mizuho Securities
Canaccord Genuity
Stifel Nicolaus
Piper Sandler
Needham & Co.
Morgan Stanley
Benchmark Company
William Blair & Co.
BTIG
Sidoti & Co.
Stephens Inc.
Jefferies & Co.
Benchmark Capital
Oppenheimer

Ratings for STAAR Surgical Company

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar